CIBC Bancorp USA
ADPT icon

CIBC Bancorp USA’s Adaptive Biotechnologies ADPT Stock Holding History

CIBC Bancorp USA’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$544K Buy
18,835
+6,468
+52% +$159K ﹤0.01% 1325
2026
Q2 		$265K Buy
12,367
+997
+9% +$15.3K ﹤0.01% 1613
2026
Q1 		$158K Buy
+11,370
New +$181K ﹤0.01% 1649
2025
Q3 		$238K Buy
+15,931
New +$194K ﹤0.01% 1189

Other funds holding ADPT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

CIBC Bancorp USA's ADPT Position: Q3 2026 in Review

CIBC Bancorp USA increased its Adaptive Biotechnologies (ADPT) stake by 52% in Q3 2026, buying an estimated $159K and bringing the position to 18,835 shares worth $544K. The position accounts for ﹤0.01% of the portfolio, ranked #1325.

CIBC Bancorp USA first reported a position in ADPT in Q3 2025 and has held it in 4 quarters since. 244 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • CIBC Bancorp USA held 18,835 shares of Adaptive Biotechnologies worth $544K as of Q3 2026.
  • CIBC Bancorp USA bought 6,468 Adaptive Biotechnologies shares in Q3 2026, an estimated $159K.
  • Adaptive Biotechnologies made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1325 holding.
  • CIBC Bancorp USA first reported a position in Adaptive Biotechnologies in Q3 2025 and has held it in 4 quarters since.
  • 244 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.